Pathogens are evolving constantly to adapt and ensure their survival. As a result they are a constantly moving target for vaccines. Some vaccines may work for a short period, whilsts others may never be able to keep up with a pathogens variation. Baseimmune uses deep learning to predict the direction that a pathogen will take to create vaccines that are many steps ahead and future proof. Introducing Baseimmune vaccines with plasticity.
Predict the Future
To Create Vaccines with Plasticity
Our technologies are based on a data-driven platform for the analysis of pathogen genomics, proteomics, epidemiology, evolution and clinical data for the generation of vaccine antigens effective against current and future unknown strains and variants.
With talented vaccine experts, scientists, bioinformaticians and software engineer in the field, Baseimmune is committed to translating ‘OMICs’ big-data into real-world solutions. By collaborating with leading institutions and companies and an expert panel of scientific advisors, we hope to develop vaccines and reduce the burden of infectious diseases in human and animal health.
The Baseimmune pipeline currently focuses on major challenges in infectious diseases. We are building a unique pipeline to address veterinary and human threats worldwide.
Our bespoke antigen discovery platform allied with superior vaccine delivery systems, allow us to fast track the discovery phase of vaccines and move faster to preclinical pipeline.
Join the team to harness the power of our computational platform to design and create variant-proof vaccines. Check our careers page for available positions.
© 2021 Baseimmune. All rights reserved
Sir Alexander Fleming Building, Imperial College London, London, SW7 2AZ